{
    "2020-12-09": [
        [
            {
                "time": "",
                "original_text": "进展最快国产疫苗！国药中生新冠疫苗在阿联酋获批上市，明年产能预计将达到超10亿剂",
                "features": {
                    "keywords": [
                        "国产疫苗",
                        "国药中生",
                        "阿联酋",
                        "获批上市",
                        "产能"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "辉瑞、阿斯利康纷纷下调发货量 海外新冠疫苗产量不及预期 原材料及产能成掣肘",
                "features": {
                    "keywords": [
                        "辉瑞",
                        "阿斯利康",
                        "发货量",
                        "海外疫苗",
                        "产能不足"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物2021年投资策略报告：不畏浮云遮望眼",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "2021年"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "分歧加剧！北上资金连续六周加仓，公募仓位降至年内低位",
                "features": {
                    "keywords": [
                        "北上资金",
                        "加仓",
                        "公募仓位",
                        "年内低位"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【行情】疫苗股午后拉升，国药股份大涨8%，国药一致、智飞生物、复星医药等个股跟涨",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "拉升",
                        "国药股份",
                        "智飞生物",
                        "复星医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块急速拉升，复星医药、康希诺-U、未名医药、智飞生物冲高",
                "features": {
                    "keywords": [
                        "疫苗板块",
                        "拉升",
                        "复星医药",
                        "康希诺-U",
                        "未名医药",
                        "智飞生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "晨报1209 | 医药&白酒2021年度策略、次新股专题、圣农发展（002299）",
                "features": {
                    "keywords": [
                        "医药",
                        "白酒",
                        "2021年度策略",
                        "次新股",
                        "圣农发展"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "白酒"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中信建投2021年医药生物投资策略展望：不畏浮云遮望眼",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药生物",
                        "投资策略",
                        "2021年"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}